← Eichor
Study identifier: NCT06285708 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Enhancing the Effectiveness of Prolonged Exposure Among Suicidal Individuals With PTSD

Condition: PTSD · Suicidal Ideation · Suicide, Attempted  ·  Sponsor: Ohio State University

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The long-term goal of this study is to reduce suicidal thoughts and behaviors among treatment-seeking individuals who also have posttraumatic stress disorder (PTSD). Prolonged exposure (PE) and crisis response plan (CRP) have demonstrated empirical support for reducing suicide attempts as compared to treatment as usual. However, no studies to date have assessed their effectiveness when used in combination. In light of this knowledge gap, the primary objective of this study will be to test the effectiveness of PE augmented with CRP as compared to PE with care as usual (self-guided treatment plan), an active comparator, for the reduction of suicide ideations and attempts for individuals with comorbid PTSD.

This description comes directly from the study's public registry record.

Talk to the study team

Jaryd Hiser, Ph.D.  ·  614-814-0163  ·  jaryd.hiser@osumc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The Ohio State UniversityColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06285708